Contact
Please use this form to send email to PR contact of this press release:
GSK announces start of Phase lll study for mepolizumab in patients with Eosinophilic Granulomatosis with Polyangiitis
TO:
Please use this form to send email to PR contact of this press release:
GSK announces start of Phase lll study for mepolizumab in patients with Eosinophilic Granulomatosis with Polyangiitis
TO: